 Mass High Tech | AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of ... MarketWatch (press release) "Iron deficiency anemia can be a debilitating condition for chronic kidney disease patients and appropriate management of this condition can carry positive clinical implications for patients. Therefore, treatment of anemia at all stages of CKD is ... LONDON, OSAKA, Japan, and LEXINGTON, Massachusetts, April 20, 2012 /PRNewswire/ -- EU committee recommends approval for Amag drug AMAG to get $30M milestone payment |
